Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride can reduce fertility in some men, but stopping it increases sperm count.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

Women with polycystic ovary syndrome tend to have a longer distance between the clitoris and anus.

Heparan sulfate is important for hair growth, preventing new hair formation in mature skin, and controlling oil gland development.

Non-classic congenital adrenal hyperplasia is a common disorder causing symptoms like acne and infertility, and it's managed based on symptoms, not just test results. Treatment can improve fertility and reduce miscarriage risk.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

Smoking harms skin health, causing slower wound healing, more wrinkles, and worsening some skin conditions, but may protect against certain others.

Oral contraceptives can cause skin issues like dark patches, acne, yeast infections, sensitivity to light, spider veins, skin rashes, and hair loss.

Group a wide range of chemicals, not just phthalates, for assessing risks to male reproductive health.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Early adrenal gland maturation in young children can be normal, but other serious conditions should be ruled out first.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Rats had lasting erectile problems after stopping a certain medication.

Hair-thread Tourniquet Syndrome, where hair or thread tightly wraps around a body part, is not rare and requires early detection to prevent serious damage.